A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance

被引：123

作者：

Fuller, JD

Low, DE

机构：

[1] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada

[2] Toronto Med Labs, Dept Microbiol, Toronto, ON, Canada

[3] Univ Toronto, Toronto, ON, Canada

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 01期

关键词：

D O I：

10.1086/430829

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We reviewed all of the published reports of cases of fluoroquinolone treatment failures for respiratory tract infection due to fluoroquinolone-resistant Streptococcus pneumoniae. There were 20 ciprofloxacin and levofloxacin treatment failures reported. Physicians should be aware, when treating pneumococcal respiratory tract infections in older patients with a fluoroquinolone, that clinical failures might occur, especially for patients with comorbid illnesses and a history of recent fluoroquinolone use.

引用

收藏

页码：118 / 121

页数：4

相关论文

共 32 条

[1] Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern:: Is it time to resight the goalposts? [J].

Ambrose, PG ;

Bast, D ;

Doern, GV ;

Iannini, PB ;

Jones, RN ;

Klugman, KP ;

Low, DE .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1554-1556

[2] Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections [J].

Ambrose, PG ;

Grasela, DM ;

Grasela, TH ;

Passarell, J ;

Mayer, HB ;

Pierce, PF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2793-2797

[3] Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia [J].

Anderson, KB ;

Tan, JS ;

File, TM ;

DiPersio, JR ;

Willey, BM ;

Low, DE .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) :376-381

[4] Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae:: data from the global PROTEKT surveillance programme [J].

Canton, R ;

Morosini, M ;

Enright, MC ;

Morrissey, I .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) :944-952

[5] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. [J].

Davidson, R ;

Cavalcanti, R ;

Brunton, JL ;

Bast, DJ ;

de Azavedo, JCS ;

Kibsey, P ;

Fleming, C ;

Low, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) :747-750

[6]

Empey PE, 2001, ANN PHARMACOTHER, V35, P687

[7] Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae:: A case-control study [J].

Ho, PL ;

Tse, WS ;

Tsang, KWT ;

Kwok, TK ;

Ng, TK ;

Cheng, VCC ;

Chan, RMT .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) :701-707

[8] Emerging mechanisms of fluoroquinolone resistance [J].

Hooper, DC .

EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :337-341

[9] The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002 [J].

Jones, ME ;

Blosser-Middleton, RS ;

Thornsberry, C ;

Karlowsky, JA ;

Sahm, DF .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (04) :579-586

[10] Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 [J].

Karlowsky J.A. ;

Jones M.E. ;

Draghi D.C. ;

Thornsberry C. ;

Sahm D.F. ;

Volturo G.A. .

Annals of Clinical Microbiology and Antimicrobials, 3 (1)

← 1 2 3 4 →